261 related articles for article (PubMed ID: 24729464)
1. Design, synthesis and anticancer activity evaluation of some novel pyrrolo[1,2-a]azepine derivatives.
Belal A
Arch Pharm (Weinheim); 2014 Jul; 347(7):515-22. PubMed ID: 24729464
[TBL] [Abstract][Full Text] [Related]
2. DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW PYRROLOAZEPINES WITH POTENTIAL AND SELECTIVE ANTITUMOR ACTIVITY.
Jaiash DA; Belal A; Abdelgawad MA; Abdellatif KR
Acta Pol Pharm; 2016; 73(2):359-68. PubMed ID: 27180428
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and molecular docking studies of 2-(furan-2-yl)quinazolin-4-one derivatives as potential antiproliferative agents.
Ahmed MF; Belal A
Arch Pharm (Weinheim); 2015 Jul; 348(7):487-97. PubMed ID: 25921702
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular docking and antitumor activity of novel pyrrolizines with potential as EGFR-TK inhibitors.
Belal A
Bioorg Chem; 2015 Apr; 59():124-9. PubMed ID: 25748126
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
[TBL] [Abstract][Full Text] [Related]
6. Pyrrolizines as Potential Anticancer Agents: Design, Synthesis, Caspase-3 activation and Micronucleus (MN) Induction.
Belal A
Anticancer Agents Med Chem; 2018; 18(15):2124-2130. PubMed ID: 29629667
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and molecular docking of new fused 1
Belal A; Abdel Gawad NM; Mehany ABM; Abourehab MAS; Elkady H; Al-Karmalawy AA; Ismael AS
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1884-1902. PubMed ID: 35801486
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activity of some novel 2-phenazinamine derivatives.
Gao X; Lu Y; Fang L; Fang X; Xing Y; Gou S; Xi T
Eur J Med Chem; 2013 Nov; 69():1-9. PubMed ID: 23995213
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
[TBL] [Abstract][Full Text] [Related]
10. Pyrrolizines: Design, synthesis, anticancer evaluation and investigation of the potential mechanism of action.
Gouda AM; Abdelazeem AH; Omar HA; Abdalla AN; Abourehab MAS; Ali HI
Bioorg Med Chem; 2017 Oct; 25(20):5637-5651. PubMed ID: 28916158
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and pharmacological evaluation of novel pyrrolizine derivatives as potential anticancer agents.
Gouda AM; Abdelazeem AH; Arafa el-SA; Abdellatif KR
Bioorg Chem; 2014 Apr; 53():1-7. PubMed ID: 24462996
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR-2 inhibitors.
El-Helby AA; Sakr H; Eissa IH; Abulkhair H; Al-Karmalawy AA; El-Adl K
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900113. PubMed ID: 31448458
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine.
White AW; Carpenter N; Lottin JR; McClelland RA; Nicholson RI
Eur J Med Chem; 2012 Oct; 56():246-53. PubMed ID: 22995819
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and molecular docking of some novel anticancer sulfonamides carrying a biologically active pyrrole and pyrrolopyrimidine moieties.
Ghorab MM; Alsaid MS; Nissan YM
Acta Pol Pharm; 2014; 71(4):603-14. PubMed ID: 25272886
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
Ghorab MM; Ragab FA; Heiba HI; Youssef HA; El-Gazzar MG
Bioorg Med Chem Lett; 2010 Nov; 20(21):6316-20. PubMed ID: 20850308
[TBL] [Abstract][Full Text] [Related]
16. Novel heterocyclic-fused pyrimidine derivatives: synthesis, molecular modeling and pharmacological screening.
Arafa RK; Nour MS; El-Sayed NA
Eur J Med Chem; 2013 Nov; 69():498-507. PubMed ID: 24090920
[TBL] [Abstract][Full Text] [Related]
17. Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities.
Abouzid KAM; Al-Ansary GH; El-Naggar AM
Eur J Med Chem; 2017 Jul; 134():357-365. PubMed ID: 28431341
[TBL] [Abstract][Full Text] [Related]
18. 5-(4-Methoxybenzylidene)thiazolidine-2,4-dione-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations.
El-Adl K; Sakr H; Nasser M; Alswah M; Shoman FMA
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000079. PubMed ID: 32515896
[TBL] [Abstract][Full Text] [Related]
19. Benzoxazole/benzothiazole-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations.
El-Helby AA; Sakr H; Eissa IH; Al-Karmalawy AA; El-Adl K
Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900178. PubMed ID: 31596514
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor activity of tetrahydrocarbazole hybridized with dithioate derivatives.
El-Nassan HB
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):308-15. PubMed ID: 24899376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]